Literature DB >> 18301065

No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population.

Babatyi I Malope1, Patrick MacPhail, Georgina Mbisa, Catherine MacPhail, Lara Stein, Edith M Ratshikhopha, Lewis Ndhlovu, Freddy Sitas, Denise Whitby.   

Abstract

BACKGROUND: The transmission of Kaposi's sarcoma herpes virus (KSHV) in men who have sex with men is clearly associated with sexual risk factors, but evidence of heterosexual transmission of KSHV is conflicting.
METHODS: Sera were obtained from 2103 South African individuals (862 miners, 95 sex workers, 731 female and 415 male township residents; mean age 33.2 years; +/- 10.1). All sera were tested for antibodies to KSHV lytic K8.1 and latent Orf73, HIV, gonococcus, herpes simplex virus type 2 (HSV-2), syphilis and chlamydia. Information on social, demographic and high-risk sexual behavior was linked to laboratory data, to evaluate risk factors, expressed as odds ratios (95% confidence interval) for KSHV.
RESULTS: Overall KSHV and HIV prevalences were 47.5 and 40%, respectively (P = 0.43). The risk of HIV infection was highest in sex workers then female residents and miners, compared with male residents (P < 0.001). HSV-2 infection was highly prevalent (66%) and lower, but still substantial, prevalences (6-8%) were observed for other sexually transmitted infections (STI). No significant difference in KSHV infection was observed among the residential groups (P > 0.05). KSHV was not associated with any of the STI or any measures of sexual behavior (P > 0.05).
CONCLUSION: The pattern of HIV and STI in sex workers suggests high rates of high-risk sexual behavior in this population. The lack of association with high-risk sexual behavior, particularly in sex workers, and with any markers of STI strongly suggest that the sexual mode does not play a significant role in KSHV transmission in this South African population.

Entities:  

Mesh:

Year:  2008        PMID: 18301065     DOI: 10.1097/QAD.0b013e3282f46582

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  29 in total

1.  Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.

Authors:  Eliane Rohner; Fabio Valeri; Mhairi Maskew; Hans Prozesky; Helena Rabie; Daniela Garone; Diana Dickinson; Cleophas Chimbetete; Priscilla Lumano-Mulenga; Izukanji Sikazwe; Natascha Wyss; Kerri M Clough-Gorr; Matthias Egger; Benjamin H Chi; Julia Bohlius
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

2.  Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda.

Authors:  Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

3.  Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda.

Authors:  Benon Biryahwaho; Sheila C Dollard; Ruth M Pfeiffer; Fatma M Shebl; Stella Munuo; Minal M Amin; Wolfgang Hladik; Ruth Parsons; Sam M Mbulaiteye
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

Review 4.  Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities.

Authors:  Susan E Krown
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

5.  Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.

Authors:  Sam M Mbulaiteye; James J Goedert
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

Review 6.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

7.  Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.

Authors:  Matthew P Fox; Mhairi Maskew; A Patrick MacPhail; Lawrence Long; Alana T Brennan; Daniel Westreich; William B MacLeod; Pappie Majuba; Ian M Sanne
Journal:  Int J Epidemiol       Date:  2012-03-20       Impact factor: 7.196

8.  Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.

Authors:  Mhairi Maskew; A Patrick MacPhail; Denise Whitby; Matthias Egger; Matthew P Fox
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

9.  Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa.

Authors:  Babatyi I Malope-Kgokong; Patrick Macphail; Georgina Mbisa; Edith Ratshikhopha; Mhairi Maskew; Lara Stein; Freddy Sitas; Denise Whitby
Journal:  Infect Agent Cancer       Date:  2010-08-31       Impact factor: 2.965

10.  Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe.

Authors:  Thomas B Campbell; Margaret Borok; Buxton Ndemera; Suzanne Fiorillo; Irene E White; Xing-quan Zhang; Rhoderick N Machekano; David Katzenstein; Lovemore Gwanzura
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.